• Latest Posts

Janssen reports positive topline phase 2 HDFN results

Beyond Biotech podcast 29: Janssen, Knowledge Gate

Janssen looks for talquetamab marketing approval

ASPIRE set up to collaborate on amyloidosis

Synairgen to collaborate on study of patients hospitalized due to respiratory viruses

Hope for children with chronic graft versus host disease as Johnson & Johnson drug approved

More News! 18 Aug 2022

Collaboration to advance investigational tuberculosis drug treatments

Yumanity selling neurology assets and merging with Kineta

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Update: First Ever Ebola Vaccine Gets US and EU Approval

European Project Launches to Tailor Autoimmune Disease Treatments

Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III